Stay updated on Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:23:05.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-23T12:44:42.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has removed detailed descriptions of a Phase 1 study for a treatment of relapsed/refractory diffuse large B-cell lymphoma, including inclusion and exclusion criteria, while adding a new revision number and a specific EudraCT number.
    Difference
    36%
    Check dated 2025-04-16T10:25:24.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:00:42.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:16:26.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T13:21:10.000Z thumbnail image

Stay in the know with updates to Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.